Scynexis
Price & Volume
Stats
See more52W Range | $3.53-$9.12 |
Market Cap | $40.5M |
Shares Short | 594,318 |
Financials
See moreRevenue (12 Mos) | $19.2M |
Revenue Growth (YoY) | -82.8% |
Gross Profit (12 Mos) | $19.2M |
Diluted EPS | -$0.89 |
News
See moreYahoo Finance • 2 months ago
SCYNEXIS Swings To Q2 Profit; Expects Phase 1 Topline Data For SCY-770 In Q3 2026;Stock Up
Yahoo Finance • 2 months ago
SCYNEXIS GAAP EPS of $0.63 beats by $1.14, revenue of $0.24M beats by $0.16M
Yahoo Finance • 5 months ago
SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 10 months ago
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
About
CEO | Dr. David Gonzalez Angulo M.D. |
Address | 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 18 |